Moreover, AhR is overexpressed in prostate cancer and cancer stem cells and it can bind to NF-κB and promote activation of MYC (Kim et al, 2000; Blum et al, 2009; Gluschnaider et al, 2010). Here, AHR is linked to prostate carcinoma.